The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. Keeping that in mind, here is one stock likely to meet or exceed Wall Street’s lofty expectations and two where its enthusiasm might be excessive.

Consensus Price Target: $46.17 (115% implied return)

Known by many for its old cable television commercials, WeightWatchers (NASDAQ:WW) is a wellness company offering a range of products and services promoting weight loss and healthy habits.

Why Do We Think WW Will Underperform?

Performance surrounding its members has lagged its peers

Performance over the past five years shows each sale was less profitable as its earnings per share dropped by 34.8% annually, worse than its revenue

Cash burn makes us question whether it can achieve sustainable long-term growth

WeightWatchers is trading at $21.45 per share, or 14.8x forward P/E. Read our free research report to see why you should think twice about including WW in your portfolio, it’s free.

Consensus Price Target: $48.43 (26.5% implied return)

With roots dating back to the pioneering days of nuclear magnetic resonance technology, Bruker (NASDAQ:BRKR) develops and manufactures high-performance scientific instruments that enable researchers and industrial analysts to explore materials at microscopic, molecular, and cellular levels.

Why Are We Cautious About BRKR?

Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth

Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 6.8 percentage points

Eroding returns on capital suggest its historical profit centers are aging

At $38.28 per share, Bruker trades at 17.2x forward P/E. Check out our free in-depth research report to learn more about why BRKR doesn’t pass our bar.

Consensus Price Target: $63.07 (54% implied return)

Originally pioneering hyperconverged infrastructure to break down traditional data center silos, Nutanix (NASDAQ:NTNX) provides a unified software platform that enables organizations to run applications and manage data across private, public, and hybrid cloud environments.

Why Does NTNX Stand Out?

Customers view its software as mission-critical to their operations as its ARR has averaged 17.6% growth over the last year

Prominent and differentiated software results in a best-in-class gross margin of 87%

Software platform has product-market fit given the rapid recovery of its customer acquisition costs

Nutanix’s stock price of $40.96 implies a valuation ratio of 4.2x forward price-to-sales. Is now the right time to buy? Find out in our full research report, it’s free.

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.